Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma
Benjamin Ziman(University of Southern California), De‐Chen Lin(University of Southern California), Chehyun Nam(University of Southern California), Neil A. Bhowmick(Cedars-Sinai Medical Center), Le Zhang(Cedars-Sinai Medical Center), Hua Zhao(University of Southern California), Qian Yang(Cedars-Sinai Medical Center), Megha Sheth(University of Southern California), Uttam K. Sinha(University of Southern California), Boyan Hu(University of Southern California), Yueyuan Zheng(Guangzhou University of Chinese Medicine)
Cited by 13
Related Papers
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k
GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs
|Nucleic Acids Research|2014|541
Role of EMT in Metastasis and Therapy Resistance
|Journal of Clinical Medicine|2016|493
Interleukin 6 and Interleukin 8 as Potential Biomarkers for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
|Archives of Otolaryngology - Head and Neck Surgery|2004|427